AlphaFold predicted structure
TRA2B · P62995

Mean pLDDT
57.6/ 100
Low
288 residues
Confidence breakdown
- Very high(≥ 90)18%
- Confident(70–90)11%
- Low(50–70)19%
- Very low(< 50)52%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
transformer 2 beta homolog
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedSevere microcephaly
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedsyndromic complex neurodevelopmental disorder
preeclampsia
Blindness
schizophrenia
Respiratory insufficiency
neurodevelopmental disorder
hereditary disease
type 2 diabetes mellitus
diabetic eye disease
diabetic retinopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Transformer-2 protein homolog beta
Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing. Can either activate or suppress exon inclusion. Acts additively with RBMX to promote exon 7 inclusion of the survival motor neuron SMN2. Activates the splicing of MAPT/Tau exon 10. Alters pre-mRNA splicing patterns by antagonizing the effects of splicing regulators, like RBMX. Binds to the AG-rich SE2 domain in the SMN exon 7 RNA. Binds to pre-mRNA
TRA2B · P62995

Mean pLDDT
57.6/ 100
Low
288 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0